RESEARCH AND DEVELOPMENT EXPENSES (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| RESEARCH AND DEVELOPMENT EXPENSES | ||
| Employee compensation and benefits | $ 7,966 | $ 6,892 |
| Clinical expense | 5,461 | 4,330 |
| License fee | 2,438 | 5 |
| Manufacturing | 2,131 | 1,535 |
| Professional services and other | 157 | 156 |
| Total research and development expenses | $ 18,153 | $ 12,918 |
| X | ||||||||||
- Definition Amount of clinical expense related to research and development. No definition available.
|
| X | ||||||||||
- Definition Amount of license fees related to research and development. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit relating to research and development. No definition available.
|
| X | ||||||||||
- Definition Amount of fee charged for services from professionals relating to research and development. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs incurred in the production of goods for sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|